Reinventing the fight against bacteria, one phage at a time.

  AMR Action Fund: Changing our approach to antibiotics 9th July 2025 © shutterstock/PeopleImages.com - Yuri A Henry Skinner, PhD, CEO of the  AMR Action Fund , illustrates the true picture of the threat of AMR and explains how the Fund is working to change the way society values antibiotics. Antimicrobial resistance (AMR) is evolving at a rapid pace and is becoming not only an increasing global health threat, but also has the potential to be a major economic burden. With this said, it is more important than ever for organisations, governments, and innovators across the globe to focus efforts and work collaboratively to eradicate the threat. Headquartered in the US, the AMR Action Fund is the world’s largest venture capital fund dedicated to investing in antimicrobial therapeutics. The Fund is designed to support companies developing potentially lifesaving antimicrobial therapeutics and was launched following conversations with the International Federation of Pharmaceutical Ma...